BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30193216)

  • 21. Synthesis and structure-activity relationship study of water-soluble carbazole sulfonamide derivatives as new anticancer agents.
    Liu Y; Wu Y; Sun L; Gu Y; Hu L
    Eur J Med Chem; 2020 Apr; 191():112181. PubMed ID: 32113125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of novel 2,3-dihydrochromeno[3,4-d]imidazol-4(1H)-one derivatives as potent anticancer cell proliferation and migration agents.
    Han X; Luo J; Wu F; Hou X; Yan G; Zhou M; Zhang M; Pu C; Li R
    Eur J Med Chem; 2016 May; 114():232-43. PubMed ID: 26994691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents.
    Zhang M; Liang YR; Li H; Liu MM; Wang Y
    Bioorg Med Chem; 2017 Dec; 25(24):6623-6634. PubMed ID: 29126741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo.
    Carrasco E; Álvarez PJ; Melguizo C; Prados J; Álvarez-Manzaneda E; Chahboun R; Messouri I; Vázquez-Vázquez MI; Aránega A; Rodríguez-Serrano F
    Eur J Med Chem; 2014 May; 79():1-12. PubMed ID: 24704691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
    Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of novel SERMs with a ferrocenyl entity based on the oxabicyclo[2.2.1]heptene scaffold and evaluation of their antiproliferative effects in breast cancer cells.
    Zheng Y; Wang C; Li C; Qiao J; Zhang F; Huang M; Ren W; Dong C; Huang J; Zhou HB
    Org Biomol Chem; 2012 Dec; 10(48):9689-99. PubMed ID: 23149805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents.
    Wu LT; Jiang Z; Shen JJ; Yi H; Zhan YC; Sha MQ; Wang Z; Xue ST; Li ZR
    Eur J Med Chem; 2016 May; 114():328-36. PubMed ID: 27017265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural development of non-secosteroidal vitamin D receptor (VDR) ligands without any asymmetric carbon.
    Misawa T; Tsuji G; Takahashi T; Ochiai E; Takagi KI; Horie K; Kakuda S; Takimoto-Kamimura M; Kurihara M; Demizu Y
    Bioorg Med Chem; 2018 Dec; 26(23-24):6146-6152. PubMed ID: 30446437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of new estradiol-cationic lipid hybrids: ten-carbon twin chain cationic lipid is a more suitable partner for estradiol to elicit better anticancer activity.
    Sudhakar G; Bathula SR; Banerjee R
    Eur J Med Chem; 2014 Oct; 86():653-63. PubMed ID: 25222876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1,25-Dihydroxyvitamin D
    Li M; Li L; Zhang L; Hu W; Shen J; Xiao Z; Wu X; Chan FL; Cho CH
    Life Sci; 2017 Jun; 179():88-97. PubMed ID: 28465245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograft.
    Govek SP; Bonnefous C; Julien JD; Nagasawa JY; Kahraman M; Lai AG; Douglas KL; Aparicio AM; Darimont BD; Grillot KL; Joseph JD; Kaufman JA; Lee KJ; Lu N; Moon MJ; Prudente RY; Sensintaffar J; Rix PJ; Hager JH; Smith ND
    Bioorg Med Chem Lett; 2019 Feb; 29(3):367-372. PubMed ID: 30587451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel β-carboline/acylhydrazone hybrids as potent antitumor agents and overcome drug resistance.
    Li Y; Yan W; Yang J; Yang Z; Hu M; Bai P; Tang M; Chen L
    Eur J Med Chem; 2018 May; 152():516-526. PubMed ID: 29754076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of D-ring fused 1,2,3-thiadiazole dehydroepiandrosterone derivatives as antitumor agents.
    Cui HW; Peng S; Gu XZ; Chen H; He Y; Gao W; Lv F; Wang JH; Wang Y; Xie J; Liu MY; Yi Z; Qiu WW
    Eur J Med Chem; 2016 Mar; 111():126-37. PubMed ID: 26866967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, antiproliferative and pro-apoptotic activity of 2-phenylindoles.
    Kelly PM; Bright SA; Fayne D; Pollock JK; Zisterer DM; Williams DC; Meegan MJ
    Bioorg Med Chem; 2016 Sep; 24(18):4075-4099. PubMed ID: 27407030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural development of p-carborane-based potent non-secosteroidal vitamin D analogs.
    Fujii S; Sekine R; Kano A; Masuno H; Songkram C; Kawachi E; Hirano T; Tanatani A; Kagechika H
    Bioorg Med Chem; 2014 Nov; 22(21):5891-901. PubMed ID: 25284253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid.
    Loch-Neckel G; Bicca MA; Leal PC; Mascarello A; Siqueira JM; Calixto JB
    Eur J Med Chem; 2015 Jan; 90():93-100. PubMed ID: 25461314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors.
    Zhai X; Bao G; Wang L; Cheng M; Zhao M; Zhao S; Zhou H; Gong P
    Bioorg Med Chem; 2016 Mar; 24(6):1331-45. PubMed ID: 26897090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and biological evaluation of non-secosteriodal vitamin D receptor ligand bearing double side chain for the treatment of chronic pancreatitis.
    Kang ZS; Wang C; Han XL; Du JJ; Li YY; Zhang C
    Eur J Med Chem; 2018 Feb; 146():541-553. PubMed ID: 29407979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
    J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the tumor-vasculature-disrupting agent verubulin and two heteroaryl analogues on cancer cells, endothelial cells, and blood vessels.
    Mahal K; Resch M; Ficner R; Schobert R; Biersack B; Mueller T
    ChemMedChem; 2014 Apr; 9(4):847-54. PubMed ID: 24678059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.